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Abstract
Purpose We evaluated if, during lithotripsy, bacteria may be detected in the irrigation fluid of percutaneous nephrolithotomy 
(PCNL) and retrograde intrarenal surgery (RIRS). The concordance between urine culture from stone fragmentation (SFUC), 
bladder (BUC), renal pelvic (RPUC) and stone (SC) was analyzed. We also assessed the correlation between variables and 
cultures and their association with systemic inflammatory response syndrome (SIRS) and of a positive SC.
Methods We included 107 patients who underwent PCNL (n = 53) and RIRS (n = 54) from January 2017 to May 2018. 
Samples for RPUC were obtained by renal catheterization. Stone fragments and irrigation fluid sample were sent for culture.
Results SFUC was positive in 17 (15.9%), BUC in 22 (20.6%), RPUC in 26 (24.3%) and SC in 30 patients (28%). The 
concordance between SFUC and SC was the highest among all cultures: 94.1%. SFUC and SC grew identical microorgan-
isms in 15/17 (88.2%) patients. Out of 17 (15.9%) patients with SIRS, 8 (7.5%) had sepsis. SFUC had the highest PPV and 
specificity to detect positive SC and SIRS. Previous urinary tract infection, a preoperative nephrostomy, stone diameter and 
composition, staghorn calculi, PCNL, positive BUC, RPUC and SFUC were predictors of infected stone. Variables that 
indicate complex stones, complex PCNL and an infection of the upper tract were associated with SIRS.
Conclusion SFUC is technically feasible, easy to retrieve and to analyze. The spectrum of SFUC potential application in 
clinical practice is when is not possible to perform a SC, e.g. complete dusting or during micro-PCNL.
Keywords Urinary tract infection · Urolithiasis · Culture media · Ureteroscopy · Percutaneous nephrolithotomy · Sepsis
Introduction
Infections are the most common complications of endouro-
logical procedures for stones. Among all patients submitted 
to percutaneous nephrolithotomy (PCNL), 10–30% develop 
fever, 35% systemic inflammatory response syndrome 
(SIRS), and 0.9–9.3% sepsis after surgery [1–3]. Using a 
standardized method for the definition and classification, 
infective complications post retrograde intrarenal surgery 
(RIRS) occur in 7.7% of patients, consisting of fever (4.4%), 
SIRS (1.7%), and sepsis (0.7%) [4].
In order to prevent infectious complications, the European 
Association of Urology guidelines on urolithiasis recom-
mend a preoperative bladder culture (BUC) and periop-
erative antibiotic prophylaxis before endourological stone 
removal [5].
However, BUC is an inaccurate predictor of infections 
following endourology, since it does not represent the 
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microbiological status of the upper urinary system, espe-
cially in cases of obstruction or infected stones [6]. Stone 
and pelvic urine cultures were found to be more accurate 
predictors of postoperative infections [7, 8].
Several pathogenic mechanisms underlying infectious 
complications after urolithiasis surgery have been postu-
lated: the bacterial colonization of stones which might not 
allow for preoperative sterilization despite targeted antibiot-
ics [9]; the release of endotoxins during lithotripsy [10, 11]; 
the generation of high intrarenal pressure, which contributes 
to pyelotubular and pyelovenous backflow and can introduce 
bacteria into systemic circulation [12, 13]; and the intrinsic 
renal vascular damage produced by the percutaneous access 
[14, 15].
Considering these factors, we postulated that stone-colo-
nizing bacteria may be disseminated in the renal collecting 
system during lithotripsy.
We evaluated the following: (i) the detection of bacteria 
released during stone fragmentation in the irrigation fluid 
and its clinical relevance; (ii) the concordance between urine 
culture during stone fragmentation (SFUC), BUC, renal pel-
vic urine culture (RPUC), and stone culture (SC); (iii) the 
correlation between the analyzed variables and cultures and 




We performed a prospective study in one academic hospital 
including all patients ≥ 18 years who underwent PCNL and 
RIRS between January 2017 and May 2018 for urolithiasis.
All patients underwent a BUC 2–3 weeks preoperatively. 
Patients with negative BUC received a first generation 
cephalosporin as perioperative prophylaxis. Patients with an 
asymptomatic bacteriuria started a targeted therapy 48–72 h 
before intervention. In cases of leukocytosis, urinary symp-
toms or fever, or a history of urosepsis, the surgery was post-
poned until after a full antibiotic course and a negative BUC.
A urine sample was collected from the renal pelvis at 
the beginning of the procedure. After lithotripsy of approx-
imately half of the stone burden, we stopped the irriga-
tion flow and continued fragmentation as long as visibil-
ity remained clear. At this moment, a sample of irrigation 
fluid was collected through the operative channel of the 
instrument.
Extracted stones were sent for SC and biochemical analy-
sis with infrared spectrophotometry.
SIRS was defined as the presence of at least 2 of the fol-
lowing criteria: fever (> 38 °C) or hypothermia, tachypnea 
(> 20 breaths per min) or  PCO2 < 32 mmHg, tachycardia 
(> 90 beats per min), leukocytosis (> 12,000 cells/mm3), 
and leukopenia (< 4000 cells/mm3). Sepsis was considered 
to be SIRS associated with suspicion or confirmation of an 
infection caused by pathogenic or potentially pathogenic 
micro-organisms [16].
In case of postoperative infectious complications, the 
prophylactic antibiotic was continued as a full-course regi-
men; non-responding patients were treated with an empiri-
cal broad-spectrum antibiotic. In all cases, the therapy was 
targeted on intraoperative culture results when available.
Complications were analyzed according to the Cla-
vien–Dindo classification [17].
Data collection followed the principles outlined in the 
Declaration of Helsinki. The ethical committee approved 
this study.
Microbiology laboratory technique
BUC was tested both for bacteria and fungi. Concerning 
the quantitative bacterial count of the urine referring to 
Kass Index [18], a growth ≥ 105 CFU/mL was considered 
as positive.
Regarding RPUC, because of the paucity of the urine 
collected from the renal pelvis, the sample was stored in 
a pediatric blood culture bottle to optimize microorganism 
growth. Stone fragments were collected in a sterile bottle 
containing 1 mL of 0.9% saline; 10 µl of the sample was 
inoculated in the same way as RPUC.
The sample retrieved during fragmentation (about 5 ml) 
was centrifuged to obtain a pellet of 1 mL, of which 10 µL 
was cultured on CPS ID3 (bioMérieux, Marcy-l’Étoile, 
France) and 10 µL on Sabouraud Dextrose Agar + CAF 
(bioMérieux), as for BUC.
Considering that Kass Index may be a weak crite-
rion to evaluate the positivity of samples other than 
midstream urine, referring to RPUC, SFUC, and SC, 
growths ≥ 103 CFU/mL were considered as positive. The 
isolated strain, monomicrobic positivity and time to detec-
tion were used to discriminate possible contamination.
In case of fever, two sets of blood samples were cultured 
on standard aerobic and anaerobic culture.
Antimicrobial susceptibility tests (AST) were performed 
in accordance with European Committee on Antimicrobial 
Susceptibility Testing criteria [19].
Surgical technique
Retrograde intrarenal surgery
After a rigid ureteroscopy, a ureteral access sheath (UAS) 
was placed (10–12 or 11–13 ch). In all patients, fragments 
were removed using baskets. A re-usable flexible scope was 
employed. A DJ stent or a ureteral catheter was placed at the 
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end of the procedure at the surgeon’s discretion. We removed 
the urethral and ureteral catheters after 24–48 h, and the DJ 
after 7–14 days. We do not routinely perform pre-stenting 
before RIRS.
Percutaneous nephrolithotomy
The renal puncture was performed under ultrasonographic 
and fluoroscopic guidance. A nephrostomic sheath was 
placed after one-shot dilation. The size of tract was decided 
according to our previously published paper [20].
Fragments were removed using the vacuum cleaner effect, 
baskets, or aspiration. An 8 ch nephrostomy tube and/or DJ 
stent or a ureteral catheter were placed at the end of the 
procedure at the surgeon’s discretion.
In the first postoperative day, the urethral and ureteral 
catheters were removed and the nephrostomy tube was 
closed. An antegrade nephrogram was taken 24–28 h after 
the procedure. The tube was removed if no extravasation or 
retained calculi were present.
In all cases of RIRS and PCNL, we used a holmium:YAG 
laser fiber for lithotripsy and a non-pressurized irrigation 
system.
Statistical analysis
Medians and interquartile ranges were reported for non-nor-
mally distributed continuous variables and frequencies for 
categorical variables. Sensitivity, specificity, positive predic-
tive value (PPV), and negative predictive value (NPV) of 
urine cultures for detecting a positive SC or postoperative 
SIRS were calculated. The associations between the ana-
lyzed factors and SIRS and positive SC were evaluated with 
logistic regression. Statistical analyses were performed using 
IBM SPSS version 21 (SPSS, Chicago, IL). Significance was 
assumed at the 0.05 level.
Results
Baseline and perioperative characteristics
The study included 107 consecutive patients: 54 underwent 
RIRS and 53 PCNL.
Table 1 depicts clinical and demographic characteristics 
of patients, stone’s parameters, and the perioperative vari-
ables. During RIRS, an UAS was used in 51/54 procedures 
(94.4%). In 26/51 patients (50.9%), a ureteral stent was posi-
tioned before the RIRS in an urgent setting for acute decom-
pression of the renal cavity.
Cultures results
A positive SFUC, BUC, RPUC, or SC was found in 17 
(15.9%), 22 (20.6%), 26 (24.3%), and 30 (28%) patients, 
respectively.
All 4 specimens were simultaneously positive in 10 
patients (9.3%) and negative in 71 (66.3%). The concordance 
between SFUC and SC was the highest among all cultures: 
94.1%, versus 86.4% for BUC and 84.6% for RPUC. SFUC 
and SC grew identical microorganisms in 15/17 (88.2%) 
patients with positive SFUC. Rather, BUC and SC had 
microbiological concordance in 12/22 (54.5%), and RPUC 
and SC in 17/26 (65.4%) patients.
Table 2 reports sensitivity, specificity, PPV, and NPV of 
BUC, RPCU, and SFUC to detect a positive SC.
In SC and RPUC, the most frequent isolated pathogen 
was E. faecalis. In contrast, the bladder urine was predomi-
nantly infected by Gram-negative pathogens. In some cases, 
SFUC were positive for a mix of the pathogens identified in 
RPUC and SC (Fig. 1 Supplementary Material).
According to SC AST, the rate of multidrug resistant 
pathogens was 16.6%, all Gram negative. Among patients 
with a positive SC, the result of this culture prompted an 
antibiotic change in six patients (20.7%) with postoperative 
infectious complications.
Infectious complications
Sixteen patients (15%) developed fever (> 38 °C). Out of 
17 (15.9%) patients with SIRS, 8 (7.5%) had sepsis. Sepsis 
requiring intensive care or septic shock never occurred.
In two cases, the blood cultures were positive for ampi-
cillin-sensitive E. faecalis: in one patient the SFUC and 
SC were positive for E. faecalis; in the other case the same 
pathogen was found in both the RPUC and SC. Among eight 
patients who developed sepsis, 6 (75%) revealed a positive 
SC and 3 (37.5%) a positive SFUC. 12/17 (70.6%) patients 
with a positive SFUC developed infectious complications, 
while only 34.6% of patients with positive RPUC had fever/
SIRS or sepsis.
Table 2 reports the sensitivity, specificity, PPV, and NPV 
of the different cultures in predicting SIRS.
Univariate analysis
Univariate logistic regression analysis revealed that previous 
urinary tract infections, a preoperative nephrostomy, stone 
diameter and composition, staghorn calculi, PCNL, and a 
positive BUC, RPUC, or SFUC were all predictors of a posi-
tive SC (Table 1 Supplementary Material).
Variables suggestive of a complex stone (stone diam-
eter, Hounsfield Units, staghorn, and infectious stones), a 
complex PCNL (operative time, multiple tracts and blood 
 World Journal of Urology
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Table 1  Peri-operative variables of patients and stone’s characteristics
Parameter Overall (n = 107) RIRS (n = 54) PCNL (n = 53)
Preoperative
Age at surgery (years) 55 (46–64) 55 (47.2–62.7) 54 (45–64)
Body mass index (kg/m2) 24.9 (22–28) 24.9 (22.3–29) 24.9 (22.8–27.9)
Male n (%) 70 (65.4%) 30 (55.6) 40 (75.5)
Female n (%) 37 (34.6%) 24 (44.4) 13 (24.5)
Charlson Comorbidity Index
0 60 (56,1%) 30 (55.6) 30 (56.6)
1 16 (14.9%) 10 (18.5) 6 (11.3)
≥ 2 31 (29%) 14 (25.9) 17 (32.1)
Diabetes n (%) 16 (15%) 11 (20.4) 5 (9.4)
Left side n (%) 55 (51.4%) 27 (50) 28 (52.8)
Right side n (%) 52 (48.6%) 27 (50) 25 (47.2)
Maximum stone diameter (mm) 14 (10–23) 10 (8.25–14) 20 (15–30)
Hounsfield units value 1000 (600–1200) 1050 (546–1253) 1000 (620.5–1180)
Single stone n (%) 36 (33.6%) 23 (42.6) 13 (24.5)
Multiple stones n (%) 71 (66.4%) 31 (57.4) 40 (75.5)
Staghorn stones n (%) 43 (40.2%) 7 (12.9) 36 (67.9)
History of previous stone surgery n (%)a 70 (65.4%) 36 (66.7) 34 (64.1)
Pre-operative DJ stent n (%) 43 (40.2%) 26 (48.1) 17 (32.1)
Pre-operative nephrostomy tube n (%) 6 (5.6%) 1 (1.8) 5 (9.4)
History of previous urinary tract infection n (%) 35 (32.7%) 15 (27.8) 20 (37.7)
Intraoperative
Operative time (minutes)b 120 (94–150) 102.5 (85–130) 138 (106–175)
Percutaneous tracts number
 1 n (%) – – 45 (84.9%)
 ≥ 2 n (%) 8 (15.1%)
PCNL type
 Mini-PCNL n (%) – – 34 (64.2%)
 Regular-PCNL n (%) 19 (35.8%)
UAS diameter
 10–12 ch n (%) – 15 (27.8) –
 11–13 ch n (%) 36 (66.7)
Exit strategy (n = 54)
 Ureteral catheter n (%) 21 (19.6) 19 (35.2%) 2 (3.7%)
 DJ stent n (%) 35 (32.7) 35 (64.8%) 0
 Nephrostomy tube n (%) 30 (28.1) 0 30 (56.6%)
 Nephrostomy tube + DJ stent n (%) 11 (10,3) 0 11 (20.8%)
 Nephrostomy tube + ureteral catheter n (%) 10 (9.3) 0 10 (18.9%)
Intraoperative complications n (%)
 Yes 11 (10.3%) 1 (1.9) 10 (18.9)
 No 96 (89.7%) 53 (98.1) 43 (81.1)
 Intraoperative stone-free status n (%)
 Yes 83 (77.6%) 46 (85.2) 37 (69.8)
 No 24 (22.4%) 8 (14.8) 16 (30.2)
Stone composition n (%)
 Calcium 63 (58.9%) 38 (70.5) 25 (47.2)
 Infectiousc 23 (21.5%) 8 (7.5) 15 (28.3)
 Uric acid 20 (18.7%) 8 (7.5) 12 (22,6)
 Cystine 1 (0.9%) 0 1 (1.9)
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transfusion), and an infection of the upper tract, but not of 
the bladder, were associated with the risk of postoperative 
SIRS (Table 2 Supplementary Material).
Discussion
We found a high concordance between SFUC and SC, sug-
gesting that the SFUC could be considered a novel tool to 
identify stone-colonizing bacteria and could potentially 
replace the need for a SC. SFUC had the highest PPV and 
specificity in detecting positive SC and SIRS.
In our study, the sensitivity and specificity of SC in pre-
dicting SIRS were lower than those reported by Mariappan 
(58.8% vs 73.7% and 77.8% vs 81.8%, respectively) [7]. 
However, in our series, SIRS and sepsis were significantly 
higher in patients with positive RPUC, SFUC, or SC but 
not in patients with a positive BUC. Our high discordance 
rate of 50% between the BUC and SC among patients with 
postoperative sepsis was similar to that reported by Nevo 
(47%) [21].
Our results demonstrate that, even when preoperative 
BUC is treated appropriately, the SC reveals the same patho-
gen in 14/22 patients (63.6%), implying that the bacteria are 
harbored inside the stone. These results confirm the findings 
from Patel et al., who found that 53% of postoperative cul-
tures grew the same bacteria identified in the preoperative 
cultures [22].
The utility of SC would be to change the antibiotic ther-
apy that would have been used based only on the BUC. The 
rate of antibiotic switching according to SC reported in the 
literature is very heterogeneous: from 1.3 to 64% [3, 21, 23, 
24]. Our rate of antibiotic switching (20.7%) confirmed the 
clinical utility of SC. On the contrary, Osman et al. reported 
that SC was clinically useful only in 1 patient with positive 
SC [25]. Despite a similar rate of SC positivity (28% in our 
series vs 29.1%), we included more patients (107 vs 79) and 
a greater number of stone variables.
Our results confirm that pathogens colonizing stones are 
different from those isolated in bladder urine [3]. Our sample 
was prevalently Gram positive in the stone and upper tract 
urine compared to predominantly Gram negative in the blad-
der. Moreover, E. faecalis was the most common pathogen 
Table 1  (continued)
Parameter Overall (n = 107) RIRS (n = 54) PCNL (n = 53)
Postoperative
Postoperative complications n (%)
 None 77 (72%) 46 (85.2%) 31 (58.5%)
 Clavien–Dindo grade I 10 (9.3%) 5 (9.3%) 5 (9.4%)
 Clavien–Dindo grade II 16 (15%) 3 (5.5%) 13 (24.5%)
 Clavien–Dindo grade IIIa 3 (2.8%) 0 3 (5.7%)
 Clavien–Dindo grade IIIb 1 (0.9%) 0 1 (1.9%)
Length of stay (days) 3 (2–6) 3 (2–3.25) 3 (3.5–7.5)
Readmission n (%)
 Yes 4 (3.7%) 1 (1.9) 3 (5.7)
 No 103 (96.3%) 53 (98.1) 50 (94.3)
Medians and interquartile ranges (IQR) for continuous variables and frequencies for categorical variables
a Included: ureteral stent, nephrostomy tube, ESWL, URS-RIRS and PCNL
b Operative time is considered as the total duration of the procedure (from the preliminary cystoscopy to the final urethral catheter placement)
c Included: magnesium ammonium phosphate and carbonate apatite
Table 2  Predicting stone culture positivity and SIRS using various specimens
Sample Sensitivity Specificity PPV NPV
For positive SC For SIRS For positive SC For SIRS For positive SC For SIRS For positive SC For SIRS
Bladder urine culture 63.3% 37.5% 96.1% 82.2% 86.4% 27.3% 86.9% 88.1%
Renal pelvic culture 73.3% 58.8% 94.8% 82.2% 84.6% 38.5% 90.1% 91.4%
Stone fragmentation 
urine culture
53.3% 41.2% 98.7% 88.9% 94.1% 41.2% 84.4% 88.9%
Stone culture / 58.8% / 77.8% / 33.3% / 90.9%
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found in the upper tract cultures of patients who developed 
SIRS and sepsis (44.4% and 50%, respectively).
These findings are consistent with many studies that con-
firmed the shift of the microbiology of stone disease during 
the last generation from predominantly Gram-negative to 
predominantly Gram-positive organisms [3, 8, 21]. There 
are many possible explanations. Several groups have docu-
mented the decreasing frequency of struvite stones in the 
neurogenic patient population [26, 27]. Moreover, the major 
advances in the urological care of patients with structural 
and neurogenic disorders have had an impact on decreasing 
stones resulting from ureolysis (usually, urea-splitting bacte-
ria are Gram negative). The developments in the minimally 
invasive treatment of urolithiasis may also be a factor in the 
microbiology of stone disease. The endoscopic treatment 
may entail repeated episodes of instrumentation of the uri-
nary tract, providing opportunities for the introduction of 
Gram-positive organisms.
Similar to the study by Korets et al. [8], our univariate 
analysis confirmed that complex stones (staghorn, infected, 
large, hard) in infected urine that require a complex PCNL 
procedure (long, with multiple access) put the patient at risk 
for SIRS. Of note, in our study, female gender was not a risk 
factor for a positive SC or for SIRS. Accordingly, in our 
cohort, the rate of positive BUC and SC was equal in both 
females and males (50% in both cases). This may be partly 
explained by the low incidence of P. mirabilis infections in 
our cohort, historically associated with struvite stones more 
common in females [28].
Especially in the subset of patients at higher risk for 
SIRS, a systematic culture of the upper tract urine and stone 
is essential for indicating the most effective postoperative 
management. Moreover, in these cases, perioperative antibi-
otic management should cover Gram-positive bacteria.
We are the first, to our knowledge, to report the use of 
SFUC during RIRS and PCNL and its correlation with SC 
and SIRS, and to investigate the role of SC during RIRS.
A recent paper analyzed the spreading of bacteria in the 
irrigation fluid and blood during RIRS, showing that 26.3% 
of patients had a positive irrigation fluid sample [29]. The 
authors concluded that irrigation fluids cultures had no role 
in predicting infectious complications. Our rate of positive 
SFUC is lower, but a direct comparison appears difficult 
because in the study from Cai et al., more than one sample 
per patients was collected, probably enhancing sensitivity. 
Moreover, intraoperatively identified strains were not cor-
related with those isolated from postoperative urine and 
blood cultures, thus neglecting the role of irrigation fluids 
cultures in prompting postoperative antibiotic therapy vari-
ations. Additionally, a direct comparison with SC was not 
performed. In our series, out of 17 patients with a positive 
SFUC, 16 had a positive SC, strengthening the hypothesis 
that during fragmentation the pathogens are released from 
the calculi.
One limitation of this study is the lack of a multivariable 
analysis to adjust for potential confounders due to the small 
number of patients with infective complications.
Obviously, our results represent the local bacterial flora, 
which may limit the applicability to other centers. Also, we 
do not discuss economic considerations, due to the variabil-
ity between different centers.
Our sepsis rate is not negligible, but probably reflects 
the complex population of our tertiary referral center and 
may be related to the adherence to the definition of sepsis as 
SIRS associated with suspicion or confirmation of a urinary 
pathogen.
It is known that SIRS may also be related to non-infec-
tious causes and can be considered oversensitive and non-
specific. However, we excluded other potential causes of 
fever, tachycardia/SIRS, such as atelectasis/pneumonia, 
hypovolemia, or uncontrolled pain.
Despite the SIRS concept being removed from The Third 
International Consensus Definitions for Sepsis and Septic 
Shock [30], we still deliberately employ it because fever 
alone cannot be used as an indicator for systemic infec-
tion, and sepsis is not common in the postoperative period. 
Moreover, the parameters used to define SIRS are easily 
measurable and reproducible in everyday urological clinical 
practice, in contrast to the Sequential Organ Failure Assess-
ment parameters [27]. Thus, SIRS criteria may still be a 
useful screening tool for identifying patients with infection.
Another limitation is the heterogeneity of our population, 
which included PCNL and RIRS patients and consequently 
different stones and techniques. We decided to include both 
surgeries because one of our primary aims was to evaluate 
the feasibility of detecting bacterial growth in the irrigation 
fluid during stone fragmentation.
Conclusions
In this study, we demonstrated that SFUC is technically fea-
sible, easy to retrieve and to analyze.
We also confirmed the utility of the SC in the postopera-
tive management of patients with infectious complications, 
including patients submitted to RIRS. In our opinion, con-
sidering the elevated microbiological concordance between 
SFUC and SC, SFUC could be useful in clinical practice 
during endourological procedures in which a stone frag-
ment cannot be sent for SC, for example, in cases of small 
calculi (e.g., the only fragment retrieved is used for stone 
analysis), complete dusting, or during micro-PCNL. Larger 
studies will be needed to investigate the clinical utility and 
cost effectiveness of SFUC during stone surgery.
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